Personalized medicine in gastric cancer: where are we and where are we going ? (2016)
Fonte: World Journal of Gastroenterology. Unidade: FMRP
Assuntos: NEOPLASIAS GÁSTRICAS, ESTÔMAGO, BIOMARCADORES, TERAPÊUTICA MÉDICA, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JÁCOME, Alexandre A. et al. Personalized medicine in gastric cancer: where are we and where are we going ?. World Journal of Gastroenterology, v. 22, n. 3, p. 1160-1171, 2016Tradução . . Disponível em: https://doi.org/10.3748/wjg.v22.i3.1160. Acesso em: 05 out. 2024.APA
Jácome, A. A., Coutinho, A. K., Lima, E. M., Andrade, A. C., & Santos, J. S. dos. (2016). Personalized medicine in gastric cancer: where are we and where are we going ? World Journal of Gastroenterology, 22( 3), 1160-1171. doi:10.3748/wjg.v22.i3.1160NLM
Jácome AA, Coutinho AK, Lima EM, Andrade AC, Santos JS dos. Personalized medicine in gastric cancer: where are we and where are we going ? [Internet]. World Journal of Gastroenterology. 2016 ; 22( 3): 1160-1171.[citado 2024 out. 05 ] Available from: https://doi.org/10.3748/wjg.v22.i3.1160Vancouver
Jácome AA, Coutinho AK, Lima EM, Andrade AC, Santos JS dos. Personalized medicine in gastric cancer: where are we and where are we going ? [Internet]. World Journal of Gastroenterology. 2016 ; 22( 3): 1160-1171.[citado 2024 out. 05 ] Available from: https://doi.org/10.3748/wjg.v22.i3.1160
